Overview

Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial

Status:
Terminated

Trial end date:
2018-10-05

Target enrollment:

Participant gender:

Summary

The purpose of this double-blinded, placebo-controlled study is to test if treatment with Botulinum toxin-A is effective in reducing chronic muscle-related pain in adults with spastic cerebral palsy.

Phase:

Phase 2

Details

Lead Sponsor:

Kristina Tedroff

Collaborators:

Danderyd Hospital
Department of Rehabilitation Medicine, Danderyd Hospital AB.
Karolinska Trial Alliance, Karolinska University Hospital Huddinge.
Karolinska University Hospital

Treatments:

abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA